CEACAM5 and neoplasm: The depletion study showed that in the absence of CD8+ T cells, the hexatherapy regimen failed to control tumor growth (p<0.0001) and prevented the animals from rejecting the MC38-CEA tumors (figure 2F; online supplemental figure 2).